Benzinga | Nov 2, 2020 07:05AM EST

Horizon Therapeutics Q3 Adj. EPS $1.74 Beats $0.94 Estimate, Sales $636.43M Beat $517.68M Estimate

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $1.74 per share which beat the analyst consensus estimate of $0.94 by 85.11 percent. This is a 171.88 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $636.43 million which beat the analyst consensus estimate of $517.68 million by 22.94 percent. This is a 89.71 percent increase over sales of $335.47 million the same period last year.